Inactive Instrument

News Ludwig Enterprises, Inc. Other OTC

Equities

LUDG

US54973P4019

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024	Mar. 19	AQ
Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	Mar. 19	CI
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers	Mar. 06	AQ
Ludwig Enterprises Inc. Announces Patent Filing for Breakthrough in Identifying Mrna Genes Associated with Certain Cancers	Mar. 06	CI
Ludwig Enterprises, Inc. announced that it has received $0.04 million in funding	Feb. 11	CI
Ludus Enterprises, Inc. Receives Continuing Review Approval on Planned Clinical Study from Advarra IRB, Columbia, MD	Jan. 31	CI
Ludwig Enterprises, Inc. Announces Executive Changes	Dec. 01	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Ludwig Enterprises, Inc. Appoints Scott Silverman as Chief Financial Officer	Nov. 16	CI
Ludwig Enterprises, Inc. Announces Marvin S. Hausman as Chief Executive Officer	23-09-19	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-21	CI
Ludwig Enterprises Announces Launches of New Nutraceutical and Strategic Marketing Plan	23-04-25	CI
Ludwig Enterprises Launches Nugenea, Groundbreaking Nutraceutical to Fight Inflammation	23-04-12	CI
Ludwig Enterprises, Inc. Auditor Raises 'Going Concern' Doubt	23-02-14	CI
Ludwig Enterprises, Inc. Receives Institutional Review Board Approval on Bladder Cancer Study	23-01-03	CI
Precision Genomics (a Ludwig Company) Will Break Major Medical News at a Presentation for LD Micro Tuesday, Oct. 25th, 2022	22-10-24	NE
Ludwig Enterprises Files A Patent That Could Be A Major Technology Breakthrough in Healthcare	22-09-22	CI
Ludwig Enterprises and Emerson Urology Associates Plan Bladder Cancer BCG Immunotherapy Study	22-09-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ludwig Enterprises, Inc. Other OTC

Equities

LUDG

US54973P4019

Summary

Filters